|
| | 09900SB1466sam002 | - 2 - | LRB099 09990 MLM 34014 a |
|
|
| 1 | | (b) Notwithstanding any general or special law to the |
| 2 | | contrary, a licensed pharmacist may dispense an opioid antidote |
| 3 | | in accordance with written, standardized procedures or |
| 4 | | protocols developed by the Department with the Department of |
| 5 | | Public Health and the Department of Human Services if the |
| 6 | | procedures or protocols are filed at the pharmacy before |
| 7 | | implementation and are available to the Department upon |
| 8 | | request. |
| 9 | | (c) Before dispensing an opioid antidote pursuant to this |
| 10 | | Section, a pharmacist shall complete a training program |
| 11 | | approved by the Department of Human Services pursuant to |
| 12 | | Section 5-23 of the Alcoholism and Other Drug Abuse and |
| 13 | | Dependency Act. The training program shall include, but not be |
| 14 | | limited to, proper documentation and quality assurance. |
| 15 | | (d) For the purpose of this Section, "opioid antidote" |
| 16 | | means a dose of naloxone hydrochloride or any other similarly |
| 17 | | acting and equally safe drug approved by the United States Food |
| 18 | | and Drug Administration.
|
| 19 | | Section 99. Effective date. This Act takes effect upon |
| 20 | | becoming law.".
|